CROP California Receives 1,000 Four Foot Cannabis Plants to Begin and Accelerate the 2019 California Cultivation Season
Momentum Public Relations
Press Release: April 18, 2019
Crop Infrastructure Corp. (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) announced today that its 49% owned Humboldt County farm has received an order of 1,000 4 ft. tall cannabis plants accelerating the company and its farm in to the 2019 cultivation season.
These large starter plants are expected to have increased yields as they are much taller and fuller than the previous years plants. Currently, the farm has five 2,000 sq.ft. greenhouses totaling 10,000 square feet and 20,000 square feet of outdoor cultivation space.
Additionally, the farm has received approval from the Humboldt County Planning Department for the 2019 expansion, including a 30,000 sq. ft. automated light dep greenhouse facility and additional vault space. The new facility is expected to cost $499,000 in capex at the farm and is expected to yield 12,000 pounds per year, taking the company to year-round cultivation and tripling the output of the existing Californiainfrastructure.
CROP’s Emerald Heights retail brand has had its licensing fees submitted for phase two of Chula Vista’scannabis retail application process, combined with the company’s partial acquisition of a distributer and extraction facility, if licenced the retail location will bring the company to being fully vertically integrated.
A report from cannabis industry research firm BDS Analytics predicts that the California cannabis market will increase to $5.1 Billion in 2019 as more dispensaries come online. Analysts at Cowen & Co. believe the nation’s legal cannabis industry could reach $50 billion by 2026, with California accounting for about $25 billion of that market, according to CFN Media Group.
CROP CEO, Michael Yorke, stated: “The company’s manufacturing partners are finishing up the farms final products of the 2018 season and now we are preparing to scale up our operations with a new state of the art facility. We will be particularly interested to see how these new, advanced plants perform.”
About CROP
Crop is publicly listed company trading under symbol CROP.CSE. The company is focused on cannabis branding and real estate assets. CROP’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada cannabis farm, 2,115 acres of Hemp CBD farms, and a growing portfolio of common share equity in upcoming listings within the cannabis space.
CROP has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line and 16 Cannabis brands.
Disclaimer for Forward-Looking Information
Certain statements in this press release are forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the expected returns from the Oklahoma Project; the technological effects of California Project; the intention to expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
The CSE has not reviewed, approved or disapproved the content of this press release.
Company Contact
Michael Yorke – CEO and Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: +1(604) 484-4206
- Published in Cannabis, CROP Infrastructure, Marijuana, News Home
Crop to Enter Oklahoma Medical Cannabis Market
Momentum Public Relations
Press Release: April 17, 2019
Crop Infrastructure Corp. (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) announced today that it has identified multiple Tenants for a roll out strategy to enter Oklahoma to target the Medical Cannabis market focusing on Cultivation, Extraction and Retail infrastructure. CROP will own 49% of the newly incorporated company.
The focus of the Oklahoma partnership will be to set up 20 acres of cultivation for medical cannabis and establish up to three retail locations. The 20 acres of medical Cannabis, once tenants are cultivating, is estimated to yield 30,000 lbs of dried flower per year. CROP has agreed to fund up to $500,000 USD for the initial start-up capital for the cultivation and retail locations.
In November 2018, an effort to place recreational cannabis on Oklahoma’s ballot fell short by 20,000 signatures. The Secretary of State’s office determined supporters of the initiative gathered only about 103,000 signatures for State Question 797. The required 123,000 signatures was not met to qualify for a public vote.
After three to five years, according to the Marijuana Business Factbook 2018, annual dispensary sales in Oklahoma are expected to generate up to $250 millionfrom medical cannabis.
The global medical cannabis market value is expected to reach a value of US$ 45.4 Billion by 2024, exhibiting a CAGR of 22.9% during 2019-2024, according to IMARC research. The firm’s estimate for last year was that it would to reach US$ 13.4 Billion.
CROP CEO, Michael Yorke, stated: “This is the 4th state where the company and its brands now have a presence. Medical cannabis is the sweet spot in this business with, potentially, very high returns on investment, so we see this as another very significant step forward in CROP’s US-focused roll-out strategy.”
About CROP
Crop is publicly listed company trading under symbol CROP.CSE. The company is focused on cannabis branding and real estate assets. CROP’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada cannabis farm, 2,115 acres of Hemp CBD farms, and a growing portfolio of common share equity in upcoming listings within the cannabis space.
CROP has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line and 16 Cannabis brands.
Disclaimer for Forward-Looking Information
Certain statements in this press release are forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the expected returns from the Oklahoma Project; the technological effects of Oklahoma Project; the intention to expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
The CSE has not reviewed, approved or disapproved the content of this press release.
Company Contact
Michael Yorke – CEO and Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: +1(604) 484-4206
- Published in Cannabis, CROP Infrastructure, Marijuana, News Home
Crop Applies for Multiple California Retail Locations and Confirms Shipment of 330,000 Pre-Rolled Cones, With Custom Evolution and Hempire Filters
Momentum Public Relations
Press Release: April 11, 2019
CROP INFRASTRUCTURE CORP. (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) announced today that its Emerald Heights retail brand has started two additional retail applications in California.
The first application, in Chula Vista, has already been notified of passing phase 1 of the licensing process. The second, in Contra Costa, has had a letter of intent submitted with the municipality and several appropriate locations have been identified. CROP’s business development team has started reviewing several existing licensed M&A opportunities in California for a flagship location.
Furthermore, CROP has confirmed with the brand product supplier that 330,000 pre-rolled cone sleeves have been shipped with custom Hempire and Evolution filters. The pre-roll equipment, located at the recently acquired NorCal distribution centre, can roll up to 10,000 cones per day with sufficient flower remaining from 2018 to fill the cones.
The current market in California for pre-rolled cones is $5.00 wholesale with an MSRP of $10.00and infused cones are wholesaled at $12.00 with a MSRP of $18.00.
“California’s cannabis market is expected to soar to $5.1 billion — and it’s going to be bigger than beer” Business Insider (Berke 2018)
A report from the cannabis industry research firm BDS Analytics estimates sales of cannabis to hit $3.7 billion by the end of 2018 alone, and predict that number will increase to $5.1 billion in 2019 as more dispensaries come online.
For comparison, beer sales in California hit $5 billion in 2017, according to industry research group IBIS World.
California — the world’s sixth largest economy with a population of close to 40 million — will be a huge chunk of the total market for cannabis in North America. Legal marijuana sales hit $9.7 billion across the seven states where recreational marijuana is legal, excluding California, and Canada in 2017 alone, according to BDS. That number is expected to hit $24.5 billion in sales by 2021, despite continued federal prohibition.
Michael Yorke states “The sales growth trend is unabated across the board. Clearly, the California market is potentially vast and, once the regulatory climate has the federal government on side, we expect sales predictions by market research firms to be sharply revised upwards and the prospect of cannabis business ending up being bigger than beer becoming much closer to a reality.”
About CROP
Crop is public company trading under symbol CROP.CSE. The company is focused on cannabis branding and real estate assets. CROP’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada cannabis farm, 2,115 acres of Hemp CBD farms, and a growing portfolio of common share equity in upcoming listings within the cannabis space.
Disclaimer for Forward-Looking Information
Certain statements in this press release are forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the expected returns from the California Project; the technological effects of California Project; the intention to expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
The CSE has not reviewed, approved or disapproved the content of this press release.
Company Contact
Michael Yorke – CEO and Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: (604) 484-4206
- Published in Cannabis, CROP Infrastructure, Marijuana, News Home
Cannara Biotech Appoints Jack Kay as New Board Director
Momentum Public Relations
Press Release: April 8, 2019
Cannara Biotech (“Cannara” or the “Company”) (CSE: LOVE FRA: 8CB), an emerging vertically integrated cannabis company focused on cultivation and cannabis-infused products, today announced the appointment of Jack Kay as a Director on Cannara’s Board, effective immediately. Mr. Kay is generally recognized as one of Canada’s leading pharmaceutical executives, having held senior positions in a number of firms, including CEO of Apotex.
“A strong and independent board is not only vital for a successful public company, it can serve as a competitive advantage in the battlefield of commerce and growth,” said Zohar Krivorot, President and CEO of Cannara Biotech. “We are thrilled to welcome Jack to Cannara, all of us are excited to learn from his insights and leadership. Jack’s track record of developing new products, launching them in Canada and elsewhere, nurturing global partnerships and spearheading a 10,000-person organization speaks for itself.”
“Like many Canadians, I’m both intrigued and excited about the prospects of cannabis to make a positive difference in the health and wellbeing of patients and non-patients alike,” said Jack Kay. “I look forward to having a more engaged role in this emerging sector, especially so with a company that has a compelling business plan and the commensurate resources to execute.”
Mr. Jack Kay, for 35 years, held various roles at Apotex Inc., including Chief Executive Officer, Chief Operating officer, President and Vice Chairman. He has 50 years’ experience in pharmaceutical management and sales. Mr. Kay has served on a number of pharmaceutical and biotech boards, including as the Chairman of Helix Biopharma Corp and Cangene Corp, and a director at Barr Pharmaceuticals Inc. He has also served in senior capacities for a number of industry and community organizations, including as the Chairman of Humber River Regional Hospital (Toronto), the International Schizophrenic Society, the Canadian Drug Manufacturers Association, the Canadian Schizophrenia Foundation and the Canadian Generic Pharmaceutical Association. Mr. Kay has degrees from both from the University of Manitoba and McGill University.
About Cannara Biotech
Cannara Biotech (CSE:LOVE) is building one of the largest indoor cannabis cultivation facilities (625,000 square feet) in Canada and the largest in Quebec. Leveraging Quebec’s low electricity costs, Cannara Biotech’s facility will produce high-grade indoor cannabis and cannabis-infused products for the Canadian and international markets.
The CSE nor its Regulation Services Provider accepts responsibility for the adequacy or accuracy of this release.
- Published in Cannabis, Cannara, Life Sciences, Marijuana, Medical Marijuana, News Home
Grown Rogue Issuance of Stock Options and Shares
Momentum Public Relations
Press Release: April 5, 2019
Grown Rogue International Inc. (CSE:GRIN | OTC: NVSIF) (“Grown Rogue” or the “Company”), is pleased to announce today that stock options have been granted to two consultants of the Company to purchase up to an aggregate of 650,000 common shares of the Company. The stock options are exercisable at a price of $0.44 per share with 150,000 of the options expiring on November 30, 2021 and 500,000 options expiring on January 1, 2022. In addition, the Company also issued a total 570,500 common shares to certain directors and officers and 241,818 common shares to a consultant, in each case, as compensation for services previously provided to the Company. The above-mentioned common shares and any common shares issued pursuant to the exercise of the stock options will be subject to a four month hold period expiring on August 6, 2019.
About Grown Rogue
Grown Rogue International (CSE: GRIN | OTC: NVSIF) is a vertically‐integrated, multi‐state cannabis company curating innovative products to provide consumers with the right cannabis experience. Each of Grown Rogue’s products and strains are categorized and marketed based on unique effects and designed for the full range of a consumers’ lifestyle. Grown Rogue is scaling the vertically integrated model into multiple states by incorporating best‐in‐class manufacturing facilities and a proprietary distribution platform based on Microsoft technology. Grown Rogue’s diverse cannabis product suite includes premium flower, patent‐pending nitrogen sealed pre‐rolls, oil and concentrates, and edibles featuring a partnership with world‐renowned chocolatier, Jeff Shepherd.
The Company is indirectly involved in the manufacture, possession, use, sale and distribution of cannabis in the recreational cannabis marketplace in the United States through its indirect operating subsidiaries. Local state laws where its subsidiaries operate permit such activities however, these activities are currently illegal under United States federal law. Additional information regarding this and other risks and uncertainties relating to the Company’s business are disclosed in the Company’s Listing Statement filed on its issuer profile on SEDAR at www.sedar.com. Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying the forward looking information or forward‐looking statements prove incorrect, actual results may vary materially from those described herein as intended, planned, anticipated, believed, estimated or expected.
No stock exchange, securities commission or other regulatory authority has approved or disapproved the information contained herein.
SOURCE Grown Rogue International Inc.
View original content: http://www.newswire.ca/en/releases/archive/April2019/05/c3397.html
Contact:
on Grown Rogue International please visit www.grownrogue.com or contact: Obie Strickler, Chief Executive Officer, obie@grownrogue.com; Jacques Habra, Chief Strategy Officer, jacques@grownrogue.com; Investor Relations Desk, Inquiries, invest@grownrogue.com
- Published in Cannabis, Grown Rogue, Marijuana, News Home
CROP’s Tenant Brands Hempire and Evolution now Available in 40 Retail Locations With Over 100 Available SKU’s
Momentum Public Relations
Press Release: April 3, 2019
CROP INFRASTRUCTURE CORP. (CSE: CROP) (OTC: CRXPF) (Frankfurt: 2FR) has been advised by its tenant brand sales team that the Hempire and Evolution brands are now available in 40 retail locations, mostly along the coastal cities of Washington.
The flower is available in eight different strains across seven sizes with concentrates being made available in five different concentrates across 20 separate strains giving the retail locations over 100 SKUS to offer their consumers.
The Washington market for 2018, according to Statista.com, was a $534.06 Million market with RBC Capital Markets analyst Nik Modi writing: ‘The legal cannabis category [in the U.S.] is set to grow at a 17% CAGR over the next decade to as much as $47 billion in annual sales.’
Crop’s tenanted Washington facility has a major advantage with low cost electricity at $0.02 per kWh and greenhouse style growing, making it one of the most efficient growing operations available in the state of Washington for high quality product.
CROP CEO, Michael Yorke, stated: “Our tenant growing team and their sales team have made outstanding progress with product placement in 40 retail locations for both flower, oils and extracts. We continue to build out our brands in California and Nevada and our objective is, ultimately, to be in as many states as possible.”
About CROP
CROP is publicly listed company trading under symbol CROP.CSE. The company is focused on cannabis branding and real estate assets. CROP’s portfolio of projects includes cultivation properties in California, two in Washington State, a 1,000-acre Nevada cannabis farm, 2,115 acres of Hemp CBD farms, and a growing portfolio of common share equity in upcoming listings within the cannabis space.
CROP has developed a portfolio of assets including Canna Drink, a cannabis infused functional beverage line and 16 Cannabis brands.
Disclaimer for Forward-Looking Information
Certain statements in this press release are forward-looking statements are not based on historical facts, but rather on current expectations and projections about future events and are therefore subject to risks and uncertainties which could cause actual results to differ materially from the future results expressed or implied by the forward-looking statements. In addition, marijuana remains a Schedule I drug under the United States Controlled Substances Act of 1970. Although Congress has prohibited the US Justice Department from spending federal funds to interfere with the implementation of state medical marijuana laws, this prohibition must be renewed each year to remain in effect. These statements generally can be identified by the use of forward-looking words such as “may”, “should”, “could”, “intend”, “estimate”, “plan”, “anticipate”, “expect”, “believe” or “continue”, or the negative thereof or similar variations. Forward-looking statements in this news release include statements regarding the expected returns from the Washington Project; the technological effects of Washington Project; the intention to expand its portfolio; and execute on its business plan. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding the regulatory and legal framework regarding the cannabis industry in general among all levels of government and zoning; risks associated with applicable securities laws and stock exchange rules relating to the cannabis industry; risks associated with maintaining its interests in its various assets; the ability of the Company to finance operations and execute its business plan and other factors beyond the control of the Company. Such forward-looking statements should therefore be construed in light of such factors, and the Company is not under any obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
The CSE has not reviewed, approved or disapproved the content of this press release.
Company Contact
Michael Yorke – CEO and Director
E-mail: info@cropcorp.com
Website: www.cropcorp.com
Phone: +1(604) 484-4206
- Published in Cannabis, CROP Infrastructure, Marijuana, News Home